Kristian D. Hindberg

Tromso, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Genetically predicted mannose-binding lectin levels and risk of future venous thromboembolism-the HUNT Study.

Genetically predicted mannose-binding lectin levels and risk of future venous thromboembolism-the HUNT Study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 17, 2025

Plasma level of human epididymis protein 4 is associated with risk of future venous thromboembolism-the Trøndelag Health study.

Plasma level of human epididymis protein 4 is associated with risk of future venous thromboembolism-the Trøndelag Health study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: October 13, 2025

Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: The HUNT Study.

Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: The HUNT Study.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 15, 2025

High concentrations of polyunsaturated n-3 fatty acids in serum are inversely associated with risk of future incident venous thromboembolism - the HUNT cohort study.

High concentrations of polyunsaturated n-3 fatty acids in serum are inversely associated with risk of future incident venous thromboembolism - the HUNT cohort study.

Journal: The American journal of clinical nutrition

Published: April 28, 2025

The Plasma Proteome and Risk of Future Venous Thromboembolism-Results from the HUNT Study.

The Plasma Proteome and Risk of Future Venous Thromboembolism-Results from the HUNT Study.

Journal: Thrombosis and haemostasis

Published: November 25, 2024

A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor.

A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor.

Journal: Blood

Published: September 20, 2024

Plasma osteopontin levels are associated with the risk of future incident venous thromboembolism-the Trøndelag Health Study (HUNT).

Plasma osteopontin levels are associated with the risk of future incident venous thromboembolism-the Trøndelag Health Study (HUNT).

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 08, 2024

Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: the HUNT study.

Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: the HUNT study.

Journal: Blood

Published: June 28, 2024

High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study.

High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study.

Journal: Blood

Published: August 22, 2023

High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism.

High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 10, 2023

Complement factors B, D, C3bBbP and risk of future venous thromboembolism.

Complement factors B, D, C3bBbP and risk of future venous thromboembolism.

Journal: Clinical immunology (Orlando, Fla.)

Published: October 05, 2022

Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.

Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.

Journal: Circulation

Published: September 26, 2022

Showing 1-12 of 55

Last Updated: 09/26/2026